Advancing neurofibromatosis and schwannomatosis clinical trial design: Consensus recommendations from the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration.

IF 2.2 3区医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL

Clinical Trials Pub Date : 2024-02-01 Epub Date: 2023-09-29 DOI:10.1177/17407745231201345

Vanessa L Merker, Andrea M Gross, Brigitte C Widemann, Scott R Plotkin

引用次数: 0

查看原文本刊更多论文

推进神经纤维瘤病和神经鞘瘤病临床试验设计：来自神经纤维瘤症和神经鞘膜瘤病反应评估（REiNS）国际合作的一致建议。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Trials 医学-医学：研究与实验

CiteScore

4.10

自引率

3.70%

发文量

审稿时长

6-12 weeks

期刊介绍： Clinical Trials is dedicated to advancing knowledge on the design and conduct of clinical trials related research methodologies. Covering the design, conduct, analysis, synthesis and evaluation of key methodologies, the journal remains on the cusp of the latest topics, including ethics, regulation and policy impact.